LARONIDASE, OTL-203, -, RITUXIMAB, FLUDARABINE, BUSULFAN, PLERIXAFOR
OTL-203-02
Phase 3 small_molecule active
Quick answer
LARONIDASE, OTL-203, -, RITUXIMAB, FLUDARABINE, BUSULFAN, PLERIXAFOR for Mucopolysaccharidosis type I, Hurler Syndrome is a Phase 3 program (small_molecule) at Orchard Therapeutics (Netherlands) B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Orchard Therapeutics (Netherlands) B.V.
- Indication
- Mucopolysaccharidosis type I, Hurler Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active